Alain Patat Selected Research

Alain Patat Research Topics

Disease

3	Infections 01/2018 - 06/2011
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2005 - 07/2001
2	Fragile X Syndrome (Martin Bell Syndrome) 05/2022 - 10/2021
2	Chronic Hepatitis C 08/2011 - 06/2011
2	Ankylosing Spondylitis 11/2004 - 05/2004
2	Psoriatic Arthritis 11/2004 - 05/2004
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2004 - 05/2004
2	Rheumatoid Arthritis 11/2004 - 05/2004
1	Intellectual Disability (Idiocy) 05/2022
1	Channelopathies 05/2022
1	Autism Spectrum Disorder 05/2022
1	Photophobia (Light Sensitivity) 05/2022
1	Autistic Disorder (Autism) 05/2022
1	Fibrosis (Cirrhosis) 01/2018
1	Osteoporosis 01/2018
1	Schizophrenia (Dementia Praecox) 01/2016
1	Parkinson Disease (Parkinson's Disease) 11/2015
1	Prostatic Neoplasms (Prostate Cancer) 07/2015
1	Breast Neoplasms (Breast Cancer) 07/2015
1	Onchocerciasis 01/2012
1	Hepatitis C 08/2011
1	Injection Site Reaction 05/2011
1	Autoimmune Diseases (Autoimmune Disease) 05/2011
1	Headache (Headaches) 01/2010
1	Alzheimer Disease (Alzheimer's Disease) 03/2009
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2008
1	Chronic Disease (Chronic Diseases) 01/2005
1	Sleep Wake Disorders 01/2005
1	Hip Fractures (Intertrochanteric Fractures) 01/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2004
1	Ascites 11/2002
1	Hyponatremia 11/2002
1	Sleepiness 04/2000
1	Sleep Deprivation 04/2000

Drug/Important Bio-Agent (IBA)

3	Antiviral Agents (Antivirals)IBA 01/2018 - 06/2011
3	Hypnotics and Sedatives (Sedatives)IBA 01/2005 - 07/2001
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2021
2	Pharmaceutical PreparationsIBA 01/2018 - 03/2008
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2004
2	danoprevirIBA 08/2011 - 06/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2004 - 05/2004
2	Etanercept (Enbrel)FDA Link 11/2004 - 05/2004
1	Retinaldehyde (Retinal)IBA 05/2022
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 05/2022
1	CalciumIBA 05/2022
1	PotassiumIBA 05/2022
1	NucleotidesIBA 01/2018
1	bazedoxifeneIBA 01/2018
1	adafosbuvirIBA 01/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	opicaponeIBA 11/2015
1	Levodopa (L Dopa)FDA LinkGeneric 11/2015
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 11/2015
1	onapristoneIBA 07/2015
1	Antiparasitic Agents (Antiparasitics)IBA 01/2012
1	moxidectinIBA 01/2012
1	InterferonsIBA 08/2011
1	Ribavirin (Virazole)FDA LinkGeneric 08/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2011
1	Viral RNAIBA 06/2011
1	PI 2301IBA 05/2011
1	Immunologic Factors (Immunomodulators)IBA 05/2011
1	Amino Acids FDA Link 05/2011
1	Bosentan (Tracleer)FDA Link 01/2010
1	EnzymesIBA 01/2010
1	lecozotanIBA 03/2009
1	Sirolimus (Rapamycin)FDA Link 03/2008
1	Vasopressins (Vasopressin)IBA 11/2002
1	zaleplon (Sonata)FDA LinkGeneric 02/2002
1	Caffeine (No Doz)FDA LinkGeneric 04/2000
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2000

Therapy/Procedure

2	Therapeutics 11/2015 - 08/2011
1	Subcutaneous Injections 05/2011
1	Drug Tapering 03/2008